Founded in 2015 by a team responsible for the FDA’s approval of the world’s first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies. Alpine Immune Sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases.
Type
Private
HQ
Seattle, US
Founded
2015
Alpine Immune Sciences was founded in 2015 and is headquartered in Seattle, US
Report incorrect company information

Key People/Management at Alpine Immune Sciences

Mitchell Gold

Mitchell Gold

Executive Chairman & CEO
Jay Venkatesan

Jay Venkatesan

President & Director
Stanford Peng

Stanford Peng

Executive VP of R&D, Chief Medical Officer
Kristine Swiderek

Kristine Swiderek

Senior VP of Research
Paul Rickey

Paul Rickey

Chief Financial Officer

Alpine Immune Sciences Office Locations

Alpine Immune Sciences has an office in Seattle
Seattle, US (HQ)
200 Elliott Avenue West
Show all (1)
Report incorrect company information

Alpine Immune Sciences Financials and Metrics

Summary Metrics

Founding Date

2015

Total Funding

$49.3 m

Latest funding size

$48 m

Time since last funding

2 years ago

Investors

Alpine Immune Sciences's latest funding round in June 2016 was reported to be $48 m. In total, Alpine Immune Sciences has raised $49.3 m
Show all financial metrics
Report incorrect company information

Alpine Immune Sciences News and Updates

Report incorrect company information